UCB
Alireza Moayyeri

Senior Director - RWE Global at UCB

  United Kingdom

About me

Dr. Alireza Moayyeri, a senior biopharmaceutical executive and physician-scientist, leverages over two decades of experience at the intersection of clinical medicine, epidemiology, and digital transformation. As Senior Director and Digital Lead for Real-World Evidence (RWE) at UCB, he is recognised for pioneering the shift from traditional data analysis to dynamic, AI-driven insights. Known as a visionary architect, Dr. Moayyeri specialises in operationalising Agentic AI and Federated Data Networks to address industry challenges such as data sovereignty, regulatory velocity, and cross-border evidence synthesis.

Schedule

My Session

Strategic Foresight: Architecting High-ROI AI Use Cases in Real-World Evidence Generation
  • Moving from RWD Infrastructure to Evidence Engines: Shifting the organizational focus from building static data lakes to deploying dynamic, AI-driven platforms that accelerate regulatory and market access decisions.
  • Agentic AI vs. traditional GenAI: Applying goal-oriented, autonomous AI agents for complex RWE tasks (e.g., automated signal detection, regulatory interpretation, and multi-step reasoning) rather than relying on basic chatbots.
  • Governing the "Loop" for Regulatory Acceptance: Designing risk-adapted oversight frameworks to successfully handle GenAI's probabilistic behaviour in deterministic regulatory settings.
  • Federated Data as the AI Enabler: Overcoming data silos and privacy constraints by deploying AI models directly to global, decentralized real-world data networks.
  • Mitigating "Validation Debt": Embedding GxP compliance, immutable audit trails, and strict security guardrails into Agentic AI workflows to ensure the validity and trustworthiness of AI-generated evidence.

Alireza Moayyeri

Senior Director - RWE Global at UCB


Real-World Data (RWD) and Evidence (RWE)
AI-Driven Innovation